References
- Tedeschi A , Camilli M , Ammirati P et al. Immune checkpoint inhibitor-associated myocarditis: from pathophysiology to rechallenge of therapy – a narrative review. Future Cardiol. 19(2), 91–103 (2023).
- Montero-Pérez-Barquero M , Escobar-Cervantes C , Arévalo-Lorido JC et al. Projected effectiveness of dapagliflozin in heart failure with reduced ejection fraction in clinical practice. Future Cardiol. 19(6), 333–342 (2023).
- Montero-Pérez-Barquero M , Escobar-Cervantes C , Arévalo-Lorido JC et al. Benefits of dapagliflozin in the whole spectrum of heart failure in clinical practice: the RICA registry. Future Cardiol. 19(6), 323–332 (2023).
- Montero-Pérez-Barquero M , Escobar-Cervantes C , Arévalo-Lorido JC et al. Projected clinical benefits of dapagliflozin in patients with heart failure with preserved ejection fraction. Future Cardiol. 19(6), 333–342 (2023).
- Ojha U , Parikh M , Patel V . Percutaneous approach for reducing outflow tract obstruction in hypertrophic obstructive cardiomyopathy. Future Cardiol. 19(4), 203–210 (2023).
- Altmetric . www.altmetric.com
- West N , Smoot K , Patzlaff N et al. Plain language summary of the INCREASE study: inhaled treprostinil (Tyvaso) for the treatment of pulmonary hypertension due to interstitial lung disease. Future Cardiol. 19(5), 229–239 (2023).
- Chan SM , Gaupp FML , Mojibian H . ClotTriever system for mechanical thrombectomy of deep vein thrombosis. Future Cardiol. 19(1), 29–38 (2023).
- Ray KK , Wright RS . Plain language summary of results from ORION-10 and ORION-11: two studies to learn how well inclisiran works in people with high cholesterol. Future Cardiol. 19(4), 175–184 (2023).
- Papakonstantinou PE , Lentza ME , Manousiadis K et al. Hyperacute synchronous cardiocerebral infarction in a patient with new-onset atrial fibrillation: a case of myocardial infarction with nonobstructive coronary arteries. Future Cardiol. 19(6), 313–322 (2023).
- Twitter . Plain Language Summaries of Publication (2023). https://twitter.com/Plainlang_FSG
- Blog . Plain Language Summaries of Publication (2023). www.plainlanguagesummaries.com/blog/
- Elliott P , Drachman BM , Gottlied SS et al. Long-term survival in people with transthyretin amyloid cardiomyopathy who took tafamidis: a plain language summary. Future Cardiol. 19(1), 7–17 (2023).
- MacRae CA , Taylor MR , Mestroni L et al. Plain language summary of publication of the safety and efficacy of ARRY-371797 in people with dilated cardiomyopathy and a faulty LMNA gene. Future Cardiol. 19(2), 55–63 (2023).
- Twitter . Future Cardiology (@fsgfca) (2023). https://twitter.com/fsgfca